0
0
The EU’s Medicines Agency (EMA) is set to make a preliminary decision on whether to approve another Corona vaccine for children. The agency’s experts will discuss Friday whether to approve the vaccine, made by U.S. manufacturer Moderna, for 12- to 17-year-olds as well. The assessment of studies by the manufacturer should be completed, the EMA said in Amsterdam. If the experts give the green light, only the EU Commission would have to approve. That is considered a formality.
The preparation “Spikevax” would then be the second Corona vaccine that may also be administered to young people in the EU. At the end of May, the vaccine from BioNTech/Pfizer had also been approved for twelve to 17-year-olds. The basis for the application by the manufacturer Moderna was a study of 2,500 adolescents in the USA. According to the company, the efficacy of the preparation was 100 percent. In addition, the preparation is said to be just as safe and tolerable for minors as for adults.
- source: k.at/picture:pixabay.com
This post has already been read 588 times!
